2m 2m 2m 2m 2m 2m 2m
AVALO THERAP (AVTX)
NASDAQ
$15.00+$0.04 (+0.30%)
Price as of Oct 02, 2026 4:42 PM EDT- $801.8MMarket Cap
- 15.00%1-Year Change
- BiotechnologyIndustry
AVALO THERAP (AVTX)
$15.00+$0.04 (+0.30%)
Earnings Score
Valuation | AVTX | vs History | vs S&P 500 |
|---|---|---|---|
Profitability | -1 | ||
Growth | -1 | ||
Low Earnings Volatility | 2 |
Momentum Score
Valuation | AVTX | vs History | vs S&P 500 |
|---|---|---|---|
3-Month Momentum | 2.54% | ||
12-Month Momentum | 46.22% | ||
3-Month Risk Adjusted Momentum | 10.02% | ||
12-Month Risk Adjusted Momentum | 57.51% |
True Yield
Valuation | AVTX | vs History | vs S&P 500 |
|---|---|---|---|
Dividend Yield | N/A | ||
Net Buyback Yield | N/A | ||
Net Debt Paydown Yield | -0.26% |
Financial Health Score
Valuation | AVTX | vs History | vs S&P 500 |
|---|---|---|---|
Ohlson's O-Score | 4 |